跳至主要内容
临床试验/IRCT201401131414N31
IRCT201401131414N31已完成3 期

Comparing the Efficacy of Nano Calcium and Marketed Calcium Supplements in Improving Bone Health in Osteopenia Population : A Randomized Clinical Trial

eutrino Noavarane Nano0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 70 years(—)
性别
All

入选标准

  • Inclusion: Osteopenia with T-Score -1 and -2.5; both male and female; Age between 45 to 70
  • Exclusion: Presence of any systemic or chronic illness such as: Chronic hepatic diseases, Clinically complicated pulmonary, cardiac, hematologic, gastrointestinal, Serious psychological problems such as severe anxiety or depression, Any diagnosed malignancy, A history of active inflammatory illness, Breast feeding, pregnancy or intention to become pregnant during the study period (female patients), Any drug hypersensitivity, Radiotherapy, Chemotherapy or any immunosuppressive drug use, Use of another investigational agent within 6 months of the screening visit, History of kidney stone, hyperparathyroidism or sarcoidosis.

排除标准

  • 未提供

研究者

发起方
eutrino Noavarane Nano

相似试验